Last updated: June 9, 2025
Sponsor: George Papanicolaou Hospital
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Emphysema
Bronchiectasis
Chronic Obstructive Lung Disease
Treatment
Oxygen
medical air
Clinical Study ID
NCT07024914
GeorgePH39/16-01-2019
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- clinical diagnosis of COPD, based on smoking history of at least 100 cigarettes andpost bronchodilation forced expiratory volume (FEV1) to forced vital capacity (FVC)ratio <0.7, and 2) resting arterial oxygen partial pressure >60 mmHg, according torecent (within a week) arterial blood gases assessment.
Exclusion
Exclusion Criteria:
- recent COPD exacerbation (as indicated by deterioration of respiratory symptoms,hospital admission and/or change in medication within the previous month), 2)history of specific balance problems (i.e., diagnosed neurological or vestibulardisorder), 3) spinal surgery, and 4) lower limb musculoskeletal problems (i.e.,surgery, injury or pathology at hip, knee, ankle or foot)
Study Design
Total Participants: 25
Treatment Group(s): 2
Primary Treatment: Oxygen
Phase:
Study Start date:
September 18, 2019
Estimated Completion Date:
December 31, 2025
Connect with a study center
Papanikolaou General Hospital
Thessaloniki, 57010
GreeceSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.